Menu
- Login
- Publications
Login
Subscribe
Scientists ID Heart-Damaging SARS-CoV-2 Protein
Scientists ID Heart-Damaging SARS-CoV-2 Protein
In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.
In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.
spike protein
US Agency to Look into Project on Modified Coronavirus
Catherine Offord | Oct 18, 2022 | 3 min read
The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.
FDA Authorizes Novavax COVID-19 Vaccine
Christie Wilcox, PhD | Jul 14, 2022 | 3 min read
Agency members express hope that the availability of a traditional, protein-based vaccine might convince holdouts to get vaccinated.
An Introduction to Glycoproteins
Rebecca Roberts, PhD | 5 min read
Making up the majority of all eukaryotic proteins, glycoproteins have a wide range of important physiological roles, from cell-cell signaling to disease pathogenesis.
Diabetes Marker Linked to COVID-19 Severity in Mice
Alejandra Manjarrez, PhD | May 16, 2022 | 3 min read
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.
Tweak to N Protein Makes Delta Variant More Infectious
Chloe Tenn | Nov 5, 2021 | 2 min read
Using a novel lab technique, researchers identified a mutation that allows the virus to insert more genetic material into host cells.
Characterizing SARS-CoV-2 Antibody Responses in COVID-19 Patients
The Scientist’s Creative Services Team and Bio-Techne | 1 min read
In this webinar, Javier Castillo-Olivares and Matteo Ferrari will discuss what they have learned about COVID-19 through testing patient sera with automated immunoblotting.
What We Know About Mu, the WHO’s Latest Variant of Interest
Christie Wilcox, PhD | Sep 7, 2021 | 2 min read
The SARS-CoV-2 variant was first detected in January, but its rising prevalence and potential resistance to vaccines has garnered it special attention from the World Health Organization.
Spike Protein Deletions Linked to COVID-19 Surges: Preprint
Alejandra Manjarrez, PhD | Jun 15, 2021 | 4 min read
Researchers find that surges in COVID-19 case numbers are associated with deletions in the SARS-CoV-2 genome in an antigenic site of the spike protein. Some of these mutations are present in vaccine breakthrough infections or reinfections.
Using Sero-Surveillance to Combat the COVID-19 Pandemic
The Scientist’s Creative Services Team and Bio-Rad Laboratories | 1 min read
Immunoassays for detecting, tracking, and testing SARS-CoV-2 antibody responses
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
First US Case of UK SARS-CoV-2 Variant Detected
Max Kozlov | Dec 30, 2020 | 4 min read
Variant B.1.1.7, though likely more contagious than other strains, does not appear to be more deadly.
Probing Antibody Binding to the SARS-CoV-2 Spike Protein
The Scientist Creative Services Team in collaboration with Refeyn | 2 min read
Victor Yin will discuss two single-particle mass analysis methods that shed light on heterogenous, multimeric proteins and their interactions.
New SARS-CoV-2 Variant Spreading Rapidly in UK
Max Kozlov | Dec 16, 2020 | 3 min read
The significance of the variant remains unclear, but experts remain confident that it will not evade the protection offered by a COVID-19 vaccine.
The Promise of mRNA Vaccines
Diana Kwon | Nov 25, 2020 | 5 min read
Long before Moderna’s and Pfizer’s COVID-19 shots, scientists had been considering the use of genetically encoded vaccines in the fight against infectious diseases, cancer, and more.
SARS-CoV-2 Antibody Durability
The Scientist’s Creative Services Team | 1 min read
Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020 | 4 min read
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Scientists Probe Blockers for the Coronavirus Spike Protein
Anthony King | Nov 5, 2020 | 6 min read
SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymie infection.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020 | 6 min read
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Modeling Study Flags Species Susceptible to SARS-CoV-2
Anthony King | Aug 26, 2020 | 4 min read
Some critically endangered animals are on the list.